FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225530675> ?p ?o ?g. }

• W4225530675 endingPage "524" @default.
• W4225530675 startingPage "515" @default.
• W4225530675 abstract "Patients with locally advanced (stage III) non-small cell lung cancer (NSCLC) demonstrate broad anatomic heterogeneity with modest survival benefits. Immune checkpoint inhibitors (ICIs) have shown survival benefit in metastatic NSCLC. We conducted this study to evaluate the efficacy and safety of neoadjuvant nivolumab in combination with chemotherapy in the treatment of this population.We retrospectively evaluated patients with locally advanced NSCLC receiving neoadjuvant nivolumab and chemotherapy (paclitaxel with carboplatin) followed by surgery at our institution from January 2019 to January 2020.A total of 46 eligible patients, 26 males, and 20 females were diagnosed with NSCLC in a stage IIIA (30 cases) and IIIB (16 cases) to receive neoadjuvant treatment. The treatment was well tolerated with just 7 (15.2%) typical immune-related adverse events (hyperthyroidism, hyperglycemia, and rash) recorded. A total of 45 patients underwent surgical resection, and 43 (95.6%) of them achieved a R0 resection. No major surgical complications were observed. There was a complete response (CR), partial response (PR), stable disease (SD), and progressive disease (PD) in 2 (4.3%), 26 (56.5%), 17 (37.0%), 6 (26.1%), and 1 (2.2%) patients. Eight patients resulted in a major pathological response (MPR) (17.4%) and 24 patients had a pathological complete response (pCR) (52.2%). At the time of data cutoff (June 1, 2021), the median follow-up period was 15.5 months (IQR 3.9-29) and 27 (60%) of 45 patients who had tumor resection were progression free. At 24 months, progression-free survival was 45.8% and overall survival was 79.9%.Nivolumab plus paclitaxel and carboplatin could be a potential neoadjuvant regimen for patients with locally advanced NSCLC, rendering a potentially lethal disease to one that is curable." @default.
• W4225530675 created "2022-05-05" @default.
• W4225530675 creator A5000432967 @default.
• W4225530675 creator A5036151282 @default.
• W4225530675 creator A5055588089 @default.
• W4225530675 creator A5066201147 @default.
• W4225530675 creator A5083881799 @default.
• W4225530675 date "2022-02-01" @default.
• W4225530675 modified "2023-10-12" @default.
• W4225530675 title "Neoadjuvant Nivolumab and Chemotherapy in Patients with Locally Advanced Non-Small Cell Lung Cancer: A Retrospective Study" @default.
• W4225530675 cites W2001210023 @default.
• W4225530675 cites W2006986876 @default.
• W4225530675 cites W2024492396 @default.
• W4225530675 cites W2071411598 @default.
• W4225530675 cites W2114238186 @default.
• W4225530675 cites W2164067249 @default.
• W4225530675 cites W2182482244 @default.
• W4225530675 cites W2464620827 @default.
• W4225530675 cites W2521503673 @default.
• W4225530675 cites W2535300095 @default.
• W4225530675 cites W2753065806 @default.
• W4225530675 cites W2796582438 @default.
• W4225530675 cites W2798160602 @default.
• W4225530675 cites W2905289065 @default.
• W4225530675 cites W2947779096 @default.
• W4225530675 cites W2982362823 @default.
• W4225530675 cites W3003526695 @default.
• W4225530675 cites W3005124847 @default.
• W4225530675 cites W3005292744 @default.
• W4225530675 cites W3007099934 @default.
• W4225530675 cites W3021010739 @default.
• W4225530675 cites W3037506839 @default.
• W4225530675 cites W3089266118 @default.
• W4225530675 cites W3120933346 @default.
• W4225530675 cites W3135468977 @default.
• W4225530675 cites W3136848998 @default.
• W4225530675 cites W3157697769 @default.
• W4225530675 cites W3193272082 @default.
• W4225530675 cites W3217720899 @default.
• W4225530675 doi "https://doi.org/10.2147/cmar.s344343" @default.
• W4225530675 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35173485" @default.
• W4225530675 hasPublicationYear "2022" @default.
• W4225530675 type Work @default.
• W4225530675 citedByCount "8" @default.
• W4225530675 countsByYear W42255306752022 @default.
• W4225530675 countsByYear W42255306752023 @default.
• W4225530675 crossrefType "journal-article" @default.
• W4225530675 hasAuthorship W4225530675A5000432967 @default.
• W4225530675 hasAuthorship W4225530675A5036151282 @default.
• W4225530675 hasAuthorship W4225530675A5055588089 @default.
• W4225530675 hasAuthorship W4225530675A5066201147 @default.
• W4225530675 hasAuthorship W4225530675A5083881799 @default.
• W4225530675 hasBestOaLocation W42255306751 @default.
• W4225530675 hasConcept C121608353 @default.
• W4225530675 hasConcept C126322002 @default.
• W4225530675 hasConcept C141071460 @default.
• W4225530675 hasConcept C143998085 @default.
• W4225530675 hasConcept C146357865 @default.
• W4225530675 hasConcept C151730666 @default.
• W4225530675 hasConcept C167135981 @default.
• W4225530675 hasConcept C197934379 @default.
• W4225530675 hasConcept C2776256026 @default.
• W4225530675 hasConcept C2776694085 @default.
• W4225530675 hasConcept C2777701055 @default.
• W4225530675 hasConcept C2778239845 @default.
• W4225530675 hasConcept C2778292576 @default.
• W4225530675 hasConcept C2778570526 @default.
• W4225530675 hasConcept C2778822529 @default.
• W4225530675 hasConcept C2780030458 @default.
• W4225530675 hasConcept C2781451048 @default.
• W4225530675 hasConcept C2908647359 @default.
• W4225530675 hasConcept C530470458 @default.
• W4225530675 hasConcept C71924100 @default.
• W4225530675 hasConcept C86803240 @default.
• W4225530675 hasConcept C99454951 @default.
• W4225530675 hasConceptScore W4225530675C121608353 @default.
• W4225530675 hasConceptScore W4225530675C126322002 @default.
• W4225530675 hasConceptScore W4225530675C141071460 @default.
• W4225530675 hasConceptScore W4225530675C143998085 @default.
• W4225530675 hasConceptScore W4225530675C146357865 @default.
• W4225530675 hasConceptScore W4225530675C151730666 @default.
• W4225530675 hasConceptScore W4225530675C167135981 @default.
• W4225530675 hasConceptScore W4225530675C197934379 @default.
• W4225530675 hasConceptScore W4225530675C2776256026 @default.
• W4225530675 hasConceptScore W4225530675C2776694085 @default.
• W4225530675 hasConceptScore W4225530675C2777701055 @default.
• W4225530675 hasConceptScore W4225530675C2778239845 @default.
• W4225530675 hasConceptScore W4225530675C2778292576 @default.
• W4225530675 hasConceptScore W4225530675C2778570526 @default.
• W4225530675 hasConceptScore W4225530675C2778822529 @default.
• W4225530675 hasConceptScore W4225530675C2780030458 @default.
• W4225530675 hasConceptScore W4225530675C2781451048 @default.
• W4225530675 hasConceptScore W4225530675C2908647359 @default.
• W4225530675 hasConceptScore W4225530675C530470458 @default.
• W4225530675 hasConceptScore W4225530675C71924100 @default.
• W4225530675 hasConceptScore W4225530675C86803240 @default.
• W4225530675 hasConceptScore W4225530675C99454951 @default.
• W4225530675 hasLocation W42255306751 @default.

• next